Massimiliano Camilli
- Cardiology and Cardiovascular Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Surgery top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Filippo CreaRocco Antonio MontoneMarco Giuseppe Del BuonoGiampaolo NiccoliCarl J. LavieSalvatore CarboneJagat NarulaGiorgio Minotti
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (24 papers)Cardiac Imaging and Diagnostics (22 papers)Cardiovascular Function and Risk Factors (16 papers)
- Cited by
- Cardiology and Cardiovascular MedicineRadiology, Nuclear Medicine and ImagingHealth, Toxicology and Mutagenesis
- Journals
- Journal of the American College of CardiologyEuropean Heart JournalJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- ItalyJapanUnited States
In The Last Decade
Massimiliano Camilli
64 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Cardiology and Cardiovascular Medicine 774
- Radiology, Nuclear Medicine and Imaging 402
- Surgery 297
- Oncology 131
- Pulmonary and Respiratory Medicine 124
Countries citing papers authored by Massimiliano Camilli
This map shows the geographic impact of Massimiliano Camilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimiliano Camilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimiliano Camilli more than expected).
Fields of papers citing papers by Massimiliano Camilli
This network shows the impact of papers produced by Massimiliano Camilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimiliano Camilli. The network helps show where Massimiliano Camilli may publish in the future.
Co-authorship network of co-authors of Massimiliano Camilli
This figure shows the co-authorship network connecting the top 25 collaborators of Massimiliano Camilli. A scholar is included among the top collaborators of Massimiliano Camilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimiliano Camilli. Massimiliano Camilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | Exposome in ischaemic heart disease: beyond traditional risk factorsbreakdown → | 43 |
| 6 | 22 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 11 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 0 | |
| 15 | 10 | |
| 16 | 9 | |
| 17 | 15 | |
| 18 | 38 | |
| 19 | 11 | |
| 20 | 26 |
About Massimiliano Camilli
Massimiliano Camilli is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Internal Medicine, having authored 77 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (24 papers), Cardiac Imaging and Diagnostics (22 papers) and Cardiovascular Function and Risk Factors (16 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (774 citations), Radiology, Nuclear Medicine and Imaging (402 citations) and Health, Toxicology and Mutagenesis (102 citations). Massimiliano Camilli has collaborated with scholars based in Italy, Japan and United States. Frequent co-authors include Filippo Crea, Rocco Antonio Montone, Marco Giuseppe Del Buono, Giampaolo Niccoli, Carl J. Lavie, Salvatore Carbone, Jagat Narula, Giorgio Minotti, Giulia Iannaccone and Carlo Trani. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.